Botulinum toxin formulations for oral administration

Details for Australian Patent Application No. 2003287463 (hide)

Owner Allergan, Inc.

Inventors Donovan, Stephen

Agent Davies Collison Cave

Pub. Number AU-B-2003287463

PCT Number PCT/US2003/0349

PCT Pub. Number WO2004/043430

Priority 10/288,906 05.11.02 US

Filing date 3 November 2003

Wipo publication date 3 June 2004

Acceptance publication date 17 January 2008

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 9/16 (2006.01) Medicinal preparations characterised by special physical form - Agglomerates

A61K 9/19 (2006.01) Medicinal preparations characterised by special physical form - lyophilised

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 38/48 (2006.01) Medicinal preparations containing peptides

Event Publications

1 April 2004 Complete Application Filed

  Priority application(s): 10/288,906 05.11.02 US

8 July 2004 Application Open to Public Inspection

  Published as AU-B-2003287463

17 January 2008 Application Accepted

  Published as AU-B-2003287463

15 May 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003287464-2'-FLUORO SUBSTITUTED OLIGOMERIC COMPOUNDS AND COMPOSITIONS FOR USE IN GENE MODULATIONS

2003287462-EDGE WEIGHTED SURGICAL DRAPE